Does a prior HoLEP change your treatment recommendation for incidentally discovered intermediate-favorable risk prostate cancer?

Active surveillance (AS) is now the preferred management for most men with low-risk prostate cancer (PC) and is also increasingly recommended for carefully selected men with intermediate-risk (IR) PC, which now comprises most newly diagnosed cases. A recent Veterans Affairs (VA) study found that ~90...

The question itself highlights the importance of proper prostate cancer screening prior to undergoing any BPH surgery. Assuming the patient had undergone proper screening (PSA, DRE, +/- MRI, +/- biopsy) and was deemed to have low suspicion for cancer or no cancer on TRUS biopsy prior to undergoing H...